| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |